The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia*

It is postulated that inadequate remodeling of the uterine spiral arteries in preeclampsia leads to focal ischemia and generation of inflammatory cytokines, such as tumor necrosis factor (TNF alpha) and interleukins (ILs), by the placenta. Our objective was to compare TNF alpha, IL-1 alpha, IL-1 beta, and IL-6 levels in placentas from patients with preeclampsia and normal term pregnancies. Because the placenta is a large heterogeneous organ, we analyzed multiple sites per placenta. On the average, there was a 3-fold variation in cytokine protein levels across the eight sites analyzed for each placenta. However, there were no significant overall differences among the normal term, preeclamptic, and preterm placentas from women without preeclampsia. There were also no significant differences in TNF alpha messenger ribonucleic acid between the normal term and preeclamptic placentas, although TNF alpha messenger ribonucleic acid levels were lower in placentas from preterm patients without diagnosis of preeclampsia than in the normal term placentas. In vitro, hypoxia stimulated the production of TNF alpha, IL-1 alpha and IL-1 beta, but not that of IL-6, by placental villous explants from both groups of patients, and this was not exaggerated in preeclampsia. Finally, although peripheral and uterine venous levels of TNF alpha were elevated in preeclamptic women compared with normal term patients, the ratio of uterine to peripheral venous TNF alpha levels was not significantly different from 1.0 for either patient group. Taken together, these results suggest that sources other than the placenta contribute to the elevated concentrations of TNF alpha and IL-6 found in the circulation of preeclamptic women.

[1]  C. Lenfant Working group report on high blood pressure in pregnancy. , 2001, Journal of clinical hypertension.

[2]  K. Conrad,et al.  Expression, Ontogeny, and Regulation of Hypoxia-Inducible Transcription Factors in the Human Placenta1 , 2000, Biology of reproduction.

[3]  D. Luthy,et al.  Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. , 1999, American journal of epidemiology.

[4]  J. N. Martin,et al.  Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. , 1999, American journal of obstetrics and gynecology.

[5]  K. Conrad,et al.  Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.

[6]  I. Sargent,et al.  Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. , 1998, American journal of obstetrics and gynecology.

[7]  I. Sargent,et al.  Interleukin-12 and pre-eclampsia. , 1997, Journal of reproductive immunology.

[8]  S. Kōzuma,et al.  Evidence for an Elevation in Serum Interleukin‐2 and Tumor Necrosis Factor‐α Levels Before the Clinical Manifestations of Preeclampsia , 1997, American journal of reproductive immunology.

[9]  K. Conrad,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Hypoxia Stimulates Cytokine Production by Villous , 2022 .

[10]  K. Conrad,et al.  Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.

[11]  G. Gamba,et al.  Semi-quantitative PCR: a tool to study low abundance messages in the kidney. , 1997, Archives of medical research.

[12]  S. Walsh,et al.  TNFα concentrations and mRNA expression are increased in preeclamptic placentas , 1996 .

[13]  A. Peaceman,et al.  Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia , 1996, Obstetrics and gynecology.

[14]  M. Mitchell,et al.  Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. , 1996, Journal of reproductive immunology.

[15]  G. Chen,et al.  Tumour necrosis factor‐alpha (TNF‐α) gene polymorphism and expression in pre‐eclampsia , 1996 .

[16]  S. Kauma,et al.  Preeclampsia Is Associated with Decreased Placental Interleukin-6 Production , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[17]  A. Waage,et al.  Interleukin‐1, interleukin‐6 and tumor necrosis factor at delivery in preeclamptic disorders , 1995, Acta obstetricia et gynecologica Scandinavica.

[18]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.

[19]  R. Silver,et al.  Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor. , 1993, American journal of obstetrics and gynecology.

[20]  J. S. Hunt,et al.  Differential distribution of interleukin-1a and interleukin-1 proteins in human placentas , 1992 .

[21]  M. Rosenblum,et al.  Recombinant human TNF-alpha: preclinical studies and results from early clinical trials. , 1992, Immunology series.

[22]  H. L. Chen,et al.  Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. , 1991, The American journal of pathology.

[23]  T. Hirano,et al.  Production of interleukin-6 by normal human trophoblast. , 1990, Placenta.

[24]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[25]  亀田 隆 Production of interleukin-6 by normal human trophoblast , 1990 .

[26]  G. Burton,et al.  Methodological problems in placental morphometry: apologia for the use of stereology based on sound sampling practice. , 1988, Placenta.

[27]  M. Jäättelä,et al.  Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. , 1988, Laboratory investigation; a journal of technical methods and pathology.